re: Ann: EU Marketing Authorisation Applicati... I agree TGA approval does not guarantee other approvals.
We have seen that with Bronchitol.
Movectro was rejected due to safety concerns. There was an increase in patients with cancer after being on the drug. It may or may not be linked but the EMEA won't take the risk and rightly so on this one.
- Forums
- ASX - By Stock
- SNT
- Ann: EU Marketing Authorisation Application Revie
Ann: EU Marketing Authorisation Application Revie, page-6
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $57.67M |
Open | High | Low | Value | Volume |
4.0¢ | 4.3¢ | 4.0¢ | $48.01K | 1.160M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1025000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 461843 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.039 |
1 | 1000000 | 0.038 |
1 | 500000 | 0.037 |
5 | 670534 | 0.036 |
5 | 985528 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 461843 | 2 |
0.043 | 263169 | 2 |
0.044 | 13167 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online